193 related articles for article (PubMed ID: 11802205)
1. The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies.
Thelin-Järnum S; Göransson M; Burguete AS; Olofsson A; Aman P
Int J Cancer; 2002 Feb; 97(4):446-50. PubMed ID: 11802205
[TBL] [Abstract][Full Text] [Related]
2. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
4. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
5. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
[TBL] [Abstract][Full Text] [Related]
6. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
[TBL] [Abstract][Full Text] [Related]
7. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
8. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.
Ron D
Curr Top Microbiol Immunol; 1997; 220():131-42. PubMed ID: 9103679
[No Abstract] [Full Text] [Related]
9. Temperature-dependent localization of TLS-CHOP to splicing factor compartments.
Göransson M; Wedin M; Aman P
Exp Cell Res; 2002 Aug; 278(2):125-32. PubMed ID: 12169268
[TBL] [Abstract][Full Text] [Related]
10. Induction of a secreted protein by the myxoid liposarcoma oncogene.
Kuroda M; Wang X; Sok J; Yin Y; Chung P; Giannotti JW; Jacobs KA; Fitz LJ; Murtha-Riel P; Turner KJ; Ron D
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5025-30. PubMed ID: 10220412
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas.
Thelin-Järnum S; Lassen C; Panagopoulos I; Mandahl N; Aman P
Int J Cancer; 1999 Sep; 83(1):30-3. PubMed ID: 10449603
[TBL] [Abstract][Full Text] [Related]
14. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.
Antonescu CR; Elahi A; Humphrey M; Lui MY; Healey JH; Brennan MF; Woodruff JM; Jhanwar SC; Ladanyi M
J Mol Diagn; 2000 Aug; 2(3):132-8. PubMed ID: 11229517
[TBL] [Abstract][Full Text] [Related]
15. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
Crozat A; Aman P; Mandahl N; Ron D
Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
[TBL] [Abstract][Full Text] [Related]
16. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
Zinszner H; Albalat R; Ron D
Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914
[TBL] [Abstract][Full Text] [Related]
17. Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6).
Hosaka T; Kanoe H; Nakayama T; Murakami H; Yamamoto H; Nakamata T; Tsuboyama T; Oka M; Kasai M; Sasaki MS; Nakamura T; Toguchida J
Oncogene; 2000 Nov; 19(50):5821-5. PubMed ID: 11126370
[TBL] [Abstract][Full Text] [Related]
18. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.
Huang HY; Antonescu CR
Ultrastruct Pathol; 2003; 27(4):217-26. PubMed ID: 12907366
[TBL] [Abstract][Full Text] [Related]
19. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
[TBL] [Abstract][Full Text] [Related]
20. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
Panagopoulos I; Mandahl N; Mitelman F; Aman P
Oncogene; 1995 Sep; 11(6):1133-7. PubMed ID: 7566973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
